Intervention Review

Rizatriptan for acute migraine

  1. Anna Oldman1,
  2. Lesley A Smith2,
  3. Henry J McQuay1,
  4. R Andrew Moore1,
  5. Sheena Derry1

Editorial Group: Cochrane Pain, Palliative and Supportive Care Group

Published Online: 24 JAN 2007

Assessed as up-to-date: 2 SEP 2001

DOI: 10.1002/14651858.CD003221.pub2

How to Cite

Oldman A, Smith LA, McQuay HJ, Moore RA, Derry S. Rizatriptan for acute migraine. Cochrane Database of Systematic Reviews 2007, Issue 1. Art. No.: CD003221. DOI: 10.1002/14651858.CD003221.pub2.

Author Information

  1. 1

    University of Oxford, Pain Research and Nuffield Department of Anaesthetics, Oxford, Oxfordshire, UK

  2. 2

    Oxford Brookes University, School of Health and Social Care, Oxford, UK

*Maura Moore, Pain Research and Nuffield Department of Anaesthetics, University of Oxford, West Wing (Level 6), John Radcliffe Hospital, Oxford, Oxfordshire, OX3 9DU, UK.

Publication History

  1. Publication Status: Withdrawn from publication for reasons stated in the review
  2. Published Online: 24 JAN 2007


Reason for withdrawal from publication

This review was withdrawn at the request of the Cochrane funding arbitration panel. There was no suggestion that the results of the review were mistaken, and it has been confirmed by other, subsequent, systematic reviews by other authors.

The review fulfilled the criteria required by The Cochrane Collaboration at the time of submission, and the source, nature, and terms of funding were discussed openly and fully. This funding included an absolute right to publish for the authors, with no interference from the funding source.

This review has now been replaced by a new published protocol: Ling R, Derry S, Moore RA, McQuay HJ, Wiffen PJ. Rizatriptan for acute migraine headaches in adults (Protocol). Cochrane Database of Systematic Reviews 2010, Issue 4. Art. No.: CD008491. DOI: 10.1002/14651858.CD008491. To view the published versions of this article, please click the 'Other versions' tab.